A randomised controlled trial of different approaches to universal antenatal Human Immunodeficiency Virus (HIV) testing: acceptability, costs and benefits

Not Applicable

Completed

• Conditions: Infection and infestations: HIV/Acquired Immunodeficiency Syndrome (AIDS); Pregnancy and childbirth: Pregnancy; Infections and Infestations; HIV

• Registration Number: ISRCTN40371436
• Lead Sponsor: Department of Health (UK)

Brief Summary

1999 Results article in https://doi.org/10.3310/hta3040 HTA monograph

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 1998-07-31
• Study Start: 2003-04-25
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 3024

Inclusion Criteria

Participants were 3024 pregnant women, of whom 2704 (89%) completed a questionnaire which determined acceptability of testing, at their booking appointment. A sub-sample of the participants (n = 788) also completed a questionnaire at their 32-week appointment.

Exclusion Criteria

Not provided at time of registration.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The main outcome measures were uptake of HIV testing, knowledge of HIV and other antenatal tests, satisfaction with the consultation, anxiety, attitudes towards pregnancy and perceived benefits of testing. Opinions about testing during pregnancy were also sought using both quantitative and qualitative measures. Midwives' knowledge and attitudes were assessed to investigate their effect on women's uptake of testing.

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration.